Development of novel therapeutic strategies that target HIF-1.
about
The human side of hypoxia-inducible factorBreast cancer chemoprevention: old and new approachesThe metal-responsive transcription factor-1 protein is elevated in human tumorsThe effect of hypoxia-inducible factor 1-alpha on hypoxia-induced apoptosis in primary neonatal rat ventricular myocytesMultiscale models of angiogenesisReal-time imaging of HIF-1alpha stabilization and degradation.Marine Natural Products as Inhibitors of Hypoxic Signaling in Tumors.Sodwanone and yardenone triterpenes from a South African species of the marine sponge Axinella inhibit hypoxia-inducible factor-1 (HIF-1) activation in both breast and prostate tumor cellsBenzochromenones from the marine crinoid Comantheria rotula inhibit hypoxia-inducible factor-1 (HIF-1) in cell-based reporter assays and differentially suppress the growth of certain tumor cell lines.Total synthesis and absolute configuration of laurenditerpenol: a hypoxia inducible factor-1 activation inhibitor.Molecular-targeted antitumor agents. 15. Neolamellarins from the marine sponge Dendrilla nigra inhibit hypoxia-inducible factor-1 activation and secreted vascular endothelial growth factor production in breast tumor cells.Latrunculin A and its C-17-O-carbamates inhibit prostate tumor cell invasion and HIF-1 activation in breast tumor cellsComparative analysis of novel and conventional Hsp90 inhibitors on HIF activity and angiogenic potential in clear cell renal cell carcinoma: implications for clinical evaluationAryl hydrocarbon nuclear translocator (hypoxia inducible factor 1beta) activity is required more during early than late tumor growthTumour necrosis is a postoperative prognostic marker for pancreatic cancer patients with a high interobserver reproducibility in histological evaluation.Control of HIF-1alpha expression by eIF2 alpha phosphorylation-mediated translational repression.Histone deacetylase inhibitors: the epigenetic therapeutics that repress hypoxia-inducible factors.Arginase II expressed in cancer-associated fibroblasts indicates tissue hypoxia and predicts poor outcome in patients with pancreatic cancerPhospholipase D1 protein coordinates dynamic assembly of HIF-1α-PHD-VHL to regulate HIF-1α stabilitySuppression of hypoxia-induced HIF-1alpha and of angiogenesis in endothelial cells by myo-inositol trispyrophosphate-treated erythrocytes.Six degrees of separation: the oxygen effect in the development of radiosensitizers.Activation of HIF-1α and LL-37 by commensal bacteria inhibits Candida albicans colonization.Short-term anti-vascular endothelial growth factor treatment elicits vasculogenic mimicry formation of tumors to accelerate metastasis.IGF1 regulates PKM2 function through Akt phosphorylationHypoxia-Inducible Factor-1: A Critical Player in the Survival Strategy of Stressed Cells.Regulation of physiological responses to continuous and intermittent hypoxia by hypoxia-inducible factor 1.The role of hypoxia inducible factor-1 in cell metabolism--a possible target in cancer therapy.Regulation of hypoxia-inducible genes by ETS1 transcription factorCalcineurin promotes hypoxia-inducible factor 1alpha expression by dephosphorylating RACK1 and blocking RACK1 dimerization.Regenerative therapy and tissue engineering for the treatment of end-stage cardiac failure: new developments and challenges.Paediatric high and low grade glioma: the impact of tumour biology on current and future therapy.Inhibition of hypoxia-inducible factors limits tumor progression in a mouse model of colorectal cancer.Regulation of lung development and regeneration by the vascular system.Hypoxia-inducible factor (HIF) inhibitors: a patent survey (2011-2015).Knockdown of Hypoxia-Inducible Factor 1α Improved the Efficacy of Low-Dose Metronomic Chemotherapy of Paclitaxel in Human Colon Cancer Xenografts.Combretastatin A4 phosphate treatment induces vasculogenic mimicry formation of W256 breast carcinoma tumor in vitro and in vivo.The hypoxic microenvironment: A determinant of cancer stem cell evolution.Maslinic acid inhibits the metastatic capacity of DU145 human prostate cancer cells: possible mediation via hypoxia-inducible factor-1α signalling.A high-fat diet increases angiogenesis, solid tumor growth, and lung metastasis of CT26 colon cancer cells in obesity-resistant BALB/c mice.Activation of the oxidative stress pathway by HIV-1 Vpr leads to induction of hypoxia-inducible factor 1alpha expression.
P2860
Q24646951-0181FC3A-EF2A-434F-BDE0-736713721779Q27693259-DB6B60B9-EA21-481D-AF7C-A1D35D6798E0Q28386210-7F47D537-D37A-49B2-AAE8-5ED74FBEFECCQ28567637-65450A50-016C-4698-BA2A-604E5A730843Q30432668-BF9C9C77-FDFD-47ED-87D0-9750998AF855Q33426848-10C5942B-EC44-4C9C-B846-D099A31BD4CAQ33980259-226E4B60-0F78-41EE-85C8-BADEB1AC2C8FQ34013112-B355FEBF-AF3F-42BA-82F2-B900E554E5D9Q34022914-3E00A770-445B-49F8-BD7C-DC67BD13EA5EQ34024182-34F359C8-386D-4602-A1BD-59F3AEC86894Q34038804-600A9E08-89C2-4B42-9D63-4E288E60D1F7Q34092083-361C7277-8B7D-41C1-AAE5-3ED0CA84FD91Q34102029-F2626A1A-F3A5-4D5B-912E-A9FCCDB0819CQ34124534-F0EC3801-BAA8-415A-93E5-3674AE27EBB5Q34250138-70CF0A20-74BB-4E13-9BE3-98F5B20BD797Q34300719-22B88530-94F7-471E-8B72-D250678D80EEQ34382527-998A5074-B69C-41D1-B234-15727929629AQ34592559-09281D94-72F1-466F-B194-DF408A9E3941Q35068054-B8AE82F9-9009-464A-898F-E4974A25D9FDQ35108335-A1635D95-AC15-453A-A701-EA8F84A50A77Q35116798-58902E9E-B353-432C-88B6-EC6D196C288AQ35832535-F138EE00-7177-41AC-A744-CDE282EFB135Q35848075-472A42F8-25A9-45D3-92BF-2EFA298D129BQ36180713-E4D783D7-29D4-4E9F-BD45-991A51C7434CQ36470446-4CF56A9A-4B8C-4256-BE7B-DDAB9DB8F97FQ36494841-654A660C-8E76-4EE6-AD4B-4F4BB95CD7D4Q36539483-87ABBD55-9099-40A6-9C63-16FE49CA6801Q36838048-48B84F6F-F743-466D-86FB-D9116CA66079Q37125538-5ADBDE00-2DA9-4E04-9675-25E50AF34DA6Q37360489-6C944887-3E93-4951-8309-83E8157EFA78Q37564201-50CEE7D7-2678-48D0-B6A8-4B0BA88B02FEQ37731507-53959A73-CF63-4886-BBFD-63C72E0DC2C0Q38430681-8D1FCA36-6CCC-4F09-8038-3713A73630C4Q38735845-B0AE5550-620C-4911-AE1F-7F8230E10F57Q38749231-1F184D17-299E-4B77-9D1E-828ACE38B01FQ38869295-2E901038-D1C3-4928-8D51-6C3215A4CB2AQ38896944-76899DB1-D855-4376-ABB1-6A3683101112Q39327962-50116B94-9FD2-42B0-80E5-397F20AC91D7Q39473547-9B9F41E9-FADF-4C03-91A8-B3ABF51A067AQ39885717-EAEA44A4-FFDE-4E54-8F79-5048FB470E4F
P2860
Development of novel therapeutic strategies that target HIF-1.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Development of novel therapeutic strategies that target HIF-1.
@ast
Development of novel therapeutic strategies that target HIF-1.
@en
type
label
Development of novel therapeutic strategies that target HIF-1.
@ast
Development of novel therapeutic strategies that target HIF-1.
@en
prefLabel
Development of novel therapeutic strategies that target HIF-1.
@ast
Development of novel therapeutic strategies that target HIF-1.
@en
P2860
P1476
Development of novel therapeutic strategies that target HIF-1.
@en
P2860
P304
P356
10.1517/14728222.10.2.267
P407
P577
2006-04-01T00:00:00Z